Certified by Founder Lodge
Ankyra Therapeutics
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $45,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 12 ,2021 | Series B | $45,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Blank Bio | $7,200,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
Kin Health | $9,000,000 | (May 20, 2026)
